< Back to search
Filter
1

A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder Cancer

for
Non-muscle Invasive Bladder Cancer,
Location: New York NY, New Brunswick NJ, Tampa FL,
Sponsor: John Sfakianos

Sex: All

Age: 18+

Code: NCT06503614

Phase2, Recruiting

Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Histology

for
Bladder Squamous Cell Carcinoma,
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 18+

Code: NCT05756569

Phase2, Recruiting

A Study for Treatment of Superficial Bladder Cancer Using OGX-427

for
Bladder Cancer
Location: Vancouver
Sponsor: Vancouver Coastal Health

Sex: All

Age: 18+

Code: NCT00959868

Phase1, Recruiting

A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC)

for
Non-Muscle Invasive Bladder Cancer
Location: Commack NY, Uniondale NY, East White Plains NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 21+

Code: NCT06929286

Phase3, Recruiting

Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers

for
Bladder Cancer
Location: Kansas City KS
Sponsor: University of Kansas Medical Center

Sex: All

Age: 18+

Code: NCT03413982

Recruiting

Interested in new bladder cancer trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder Cancer

for
Bladder Cancer, Muscle-Invasive Bladder Carcinoma,
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: All

Age: 18+

Code: NCT06470282

Phase1, Phase2, Recruiting

A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and Upper Tract Urothelial Cancer, Get Moving Trial

for
Bladder Cancer, Urothelial Carcinoma,
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT06040762

Recruiting

In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial

for
Non-Muscle Invasive Bladder Carcinoma,
Location: Jacksonville FL
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06704191

Phase1, Phase2, Recruiting

Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue

for
Bladder Cancer, Urinary Tract Cancer, Urothelial Cancer,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT02379429

Recruiting

A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.

for
Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma,
Location: Fairfax VA, Pittsburgh PA, Canton OH, Columbus OH,
Sponsor: OncoNano Medicine, Inc.

Sex: All

Age: 18+

Code: NCT06022029

Phase1, Recruiting

Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients

for
Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG,
Location: Halifax, Montreal, Syracuse NY, Myrtle Beach SC,
Sponsor: Theralase® Technologies Inc.

Sex: All

Age: 18+

Code: NCT03945162

Phase2, Recruiting

A Beta-only IL-2 ImmunoTherapY Study

for
Advanced Solid Tumor, Unresectable Solid Tumor,
Location: Boca Raton FL, Toronto, Detroit MI, Atlanta GA,
Sponsor: Medicenna Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05086692

Phase1, Phase2, Recruiting

Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol

for
Bladder Cancer
Location: Boston MA
Sponsor: Brigham and Women's Hospital

Sex: All

Age: 18 - 70+

Code: NCT03216525

Phase3, Recruiting

Evaluating Safety and Efficacy of Prostate-sparing Radical Cystectomy

for
Bladder Cancer
Location: Baltimore MD, Washington D.C. DC
Sponsor: Johns Hopkins University

Sex: Male

Age: 18+

Code: NCT05792722

Recruiting

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

for
Superficial Bladder Cancer,
Location: Halifax, Boston MA, New Haven NY, Albany NY,
Sponsor: enGene, Inc.

Sex: All

Age: 18+

Code: NCT04752722

Phase1, Phase2, Recruiting

Intravesical Gemcitabine and Docetaxel for Low Grade Intermediate Risk Bladder Cancer

for
Bladder Cancer
Location: Gainesville FL
Sponsor: University of Florida

Sex: All

Age: 18+

Code: NCT06488222

Phase2, Recruiting

A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

for
Non-Muscle Invasive Bladder Cancer
Location: Boston MA, New York NY, Los Alamitos CA,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06319820

Phase3, Recruiting

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

for
Non-Muscle Invasive Bladder Urothelial Carcinoma,
Location: Boston MA, Quebec, Commack NY, Berlin Corners VT,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06770582

Phase2, Recruiting

Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer

for
Intermediate Risk Non-Muscle Invasive Bladder Cancer
Location: Boston MA, Garden City NY, New York NY, Lake Success NY,
Sponsor: Ferring Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06510374

Phase3, Recruiting

Neoadjuvant Upper Tract Invasive Cancer Trial (NAUTICAL)

for
Bladder Cancer, Bladder Urothelial Carcinoma
Location: Ottawa, Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT04574960

Phase3, Recruiting